Joseph Stubbs, MD
Urogynecology and Reconstructive Pelvic Surgery · Savannah, GANPI 1578592135
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (46.7%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Intuitive Surgical at 48.5% of the total. 2025 is the largest year on record at $7,550, 8.3 times the $915 reported in 2019.
Across 118 payments — averaging $108.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$6K
- Medtronic$3K
- Boston Scientific$2K
- Axonics, Inc.$1K
- Caldera Medical, Inc$61
- AbbVie$32
- plus $97 from 4 others
What the payments were for
- Speaking & faculty fees$2,27318%
- Travel & lodging$2,72621%
- Food & beverage$1,79914%
- Education$6,00047%
- Gifts$610%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 5 | $6,237 |
| Medtronic(2 entities) | 32 | $3,445 |
| Boston Scientific | 15 | $1,764 |
| Axonics, Inc. | 58 | $1,223 |
| Caldera Medical, Inc | 1 | $61 |
| AbbVie | 2 | $32 |
| Novo Nordisk | 2 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Nestle Healthcare Nutrition Inc. | 1 | $23 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$6,150
- INTERSTIM$2,000
- UPSYLON$929
- ADVANTAGE$532
- Axonics$273
How this compares
$12,859 in reported general payments places this provider in the 75th percentile of 32 urogynecology and reconstructive pelvic surgery providers in Georgia.
See all urogynecology and reconstructive pelvic surgery providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 96 | $59,763 |
| GemtesaVibegron | 65 | $38,456 |
| Estradiol | 170 | $13,450 |
| YuvafemEstradiol | 29 | $3,173 |
| Estradiol (Twice Weekly)Estradiol | 36 | $2,731 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 120 | $1,335 |
| Clobetasol Propionate | 27 | $1,166 |
| Oxybutynin Chloride ErOxybutynin Chloride | 80 | $599 |
| Oxybutynin Chloride | 40 | $429 |
| ProgesteroneProgesterone, Micronized | 13 | $424 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 92 | $415 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 111 | $266 |
| Levofloxacin | 20 | $142 |
| NitrofurantoinNitrofurantoin Macrocrystal | 11 | $104 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $92 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $24 | $38,45665 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 32 urogynecology and reconstructive pelvic surgery providers in Georgia.
Other urogynecology and reconstructive pelvic surgery in Savannah
- Barry SchlafsteinSavannah$2K
- Jason BaileyGainesville$369K
- Cheau WilliamsMoultrie$192K
- David LovejoyMacon$85K
- Anne WiskindAtlanta$51K
- Barbara HenleyAugusta$37K
- Ivrose JosephAugusta$17K
- Jennifer LanzerGainesville$16K
- Danielle TaylorAugusta$10K
- Joye LowmanAtlanta$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.